Broad regulatory authority provided to state regulators has proven to be more effective than the enactment of issue-specific state legislation in reining in business tactics commonly employed by pharmacy benefit managers (PBMs) that contribute to increased drug spending by state governments, according to regulators from four out of five states studied for a new report released Monday (April 15) by the Government Accountability Office (GAO). The report found even without the passage of new legislation, broad authority for regulators to...